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Introduction
Familial Mediterranean Fever (FMF) is an autoinflamma-
tory disease. It is associated with vasculitis, pulmonary
hemorrhage, infiltrates, and pulmonary hypertension due
to amyloidosis. These complications however have been
reported only rarely.
Objectives
The aim of our study was to investigate pulmonary conse-
quences of FMF.
Methods
The study cohort involved 155 FMF patients (male/female
87/68). Mean age was 33,6±11,8 years in the patients
group without renal amyloidosis (45 men, 35 women,
n=80) and 37,8±7,4 years in the patients group with amy-
loidosis (42 men, 33 women, n=75). All the patients had
symptoms related to the respiratory system, such as
pleuritic chest pain with or without cough, dyspnea, chest
tightness and frequent pneumonias. 28 patients had a his-
tory of tobacco use. Most of the patients (122) had
M694V mutation, and the rest had other mutations. All
the patients were on colchicine treatment at the time of
the study with the exception of 2 hemodialysis patients.
Laboratory tests, including CRP, SAA and capillary blood
gases, ECG and chest X-ray were carried out on all the
patients. 50 patients underwent Doppler echocardiography
and 25 HRCT scan of the chest.
Results
Mean C-reactive protein (CRP) and serum amyloid-A
(SAA) were 17.74±13.74 mg/L vs 11,88±13.79 mg/L and
33±66.6 mg/L vs 5.25±4,45mg/L, respectively, and signifi-
cantly higher in the patients group with renal amyloidosis
than the mean values of the patients group without amy-
loidosis (P<0,000). Blood gases values (mean±SD) were
within normal ranges in patients without amyloidosis,
and were slightly decreased in amyloidosis patients group
(PO2 83.6±8.95 mm Hg, PCO2 39.4±3.6 mmHg, O2Sat
94.6±3.38% vs. PO2 74±11.36 mm Hg, PCO2 35.3±4.5 mm
Hg, O2Sat 90.1±10.26%, P<0.000). Infiltrates, ground-glass
opacities, reticulonodular pattern, pleural effusion and
pleural thickening, lymphadenopathy, dilatation and
hypertrophy of right ventricle and increased pulmonary
artery systolic pressure were more frequent findings in the
patients group with amyloidosis than in the group without
it, though in the group without amyloidosis they occurred
as well.
Conclusion
Our results suggest that patients with FMF and amyloi-
dosis tend to have hypoxemia. The latter could contri-
bute to pulmonary complications in FMF patients. On
the other hand, it is possible that FMF patients without
renal amyloidosis experience pulmonary manifestations
and develop pulmonary complications. Respiratory symp-
toms in FMF patients without renal amyloidosis probably
result from ongoing inflammation and early vascular
alteration. Hypoxemia is a sign of advanced disease.
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